Related Experiment Videos
Post bone marrow transplant sera and persisting mast cell colonies
1Haematology Department, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Bone Marrow Transplantation
|January 1, 1988
Summary
Serum from bone marrow transplant (BMT) recipients promotes mast cell growth. This mast cell stimulating activity in post-BMT serum may be linked to graft-versus-host disease (GVHD).
Area of Science:
- Immunology
- Hematology
- Transplantation immunology
Background:
- Allogeneic bone marrow transplantation (BMT) is a complex procedure with potential complications.
- Graft-versus-host disease (GVHD) is a significant concern following BMT.
- Mast cells play a role in immune responses and inflammation.
Purpose of the Study:
- To investigate serum activity influencing mast cell growth in BMT recipients.
- To determine if BMT serum affects mast cell colony formation compared to normal controls.
- To explore potential associations between mast cell stimulating activity and BMT outcomes.
Main Methods:
- Serum samples were collected from eight allogeneic bone marrow transplant recipients at different time points post-transplant.
- Mast cell colony growth was assessed using long-term agar cultures.
- Neutrophil, monocyte, and eosinophil colony formation were also evaluated.
- Samples were compared to normal control sera.
Main Results:
- Post-BMT serum samples significantly increased mast cell colony growth compared to normal controls (p < 0.025-0.005).
- This effect was observed irrespective of time post-BMT or the presence of clinical GVHD.
- Neutrophil, monocyte, and eosinophil colony numbers were not significantly different between BMT recipients and controls.
Conclusions:
- Post-BMT serum contains elevated mast cell stimulating activity.
- This activity may be a marker for subclinical or clinical GVHD.
- Further research is needed to identify the specific mast cell stimulating factors in BMT serum.